Skip to main content

Table 3 Univariable and multivariable analysis of risk factors correalted with new-onset AS

From: Decreased expression of NAT10 in peripheral blood mononuclear cells from new-onset ankylosing spondylitis and its clinical significance

 

Univariate analysis

Multivariate analysis

 

OR

95% CI

P-value

OR

95% CI

P-value

L%

-0.209

0.745–0.884

 < 0.0001

   

N%

0.215

1.133–1.357

 < 0.0001

0.200

1.009–1.478

0.040

NAT10

-0.651

0.331–0.822

 < 0.0001

-0.790

0.262–0.786

0.005

  1. AS ankylosing spondylitis, L% lymphocyte percentages, NAT10 N-acetyltransferase 10, N% neutrophil percentages